Spotlight on Piramal Pharma Solutions, Canada

Published: 16-Jun-2021

Taking a closer look at the company's facility in Ontario

The Aurora, Canada facility is a USFDA, Health Canada and PMDA inspected site which offers development, clinical and commercial GMP manufacturing of Active Pharmaceutical Ingredients (APIs) for complex pharmaceutical NCEs.

Specialized Capabilities

  • 14 plant scale reactors ranging between 200 - 2000 L (stainless steel/glass-lined)
  • Stand-alone hydrogenation facility
  • Kilo lab suites, 50 - 100 L reactors
  • Non-GMP scale-up suites, 50 L reactors
  • Drying, milling and packaging facility
  • Small scale GMP laboratory

Featured Services

  • Process/route selection
  • Process development for GMP scale-up
  • Analytical method development, validation and stability studies
  • GMP manufacturing from grams to 100s’ kg scale
  • Commercial API launch• High potent APIs manufacturing
  • CMC filing support

Salient Features

  • State of the art lab services, production plants, and kilo-lab suites
  • US FDA, Health Canada and PMDA Japan inspected, no critical observations/483s in the past 10 years
  • 24/7 operation

You may also like